Skip to main content

Table 4 Changes in migraine and headache frequency during use of the progestin-only pill desogestrel 75 μg, comparison between MO (n=32) and MA (10) patients

From: Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days

 

MO Mean (SD) baseline

MA Mean (SD) baseline

MO Mean (SD) TP 2

MA Mean (SD) TP 2

p-value MO baseline vs. TP 2

p-value MA baseline vs. TP 2

Headache days/month

4.1 (4.3)

3.8 (5.2)

3.4 (4.6)

1.9 (2.0)

0.06

0.60

Migraine days/month

5.4 (4.1)

6.8 (4.8)

3.2 (3.8)

4.6 (4.3)

0.007

0.09

Sum headache and migraine/month

9.5 (5.6)

8.8 (3.6)

6.6 (4.4)

6.6 (4.4)

<0.001

0.11

Headache intensity/month

16.0 (8.3)

14.4 (5.4)

11.4(8.4)

8.5 (6.4)

<0.001

0.24

Pain medication

6.2 (3.6)

9.8 (9.5)

4.7 (3.6)

5.8 (4.8)

0.03

0.03

Triptan use in 3 months

11.9 (11.8)

13.1 (22.2)

8.4 (10.7)

6.2 (8.6)

0.005

0.02

  1. MO = migraine without aura, MA = Migraine with aura, baseline : days 1–90 before treatment; TP 2: days 91–180 of treatment.